Bharat Biotech’s intranasal Covid vaccine has been approved by the Union Health Ministry.
the needle-free vaccine will be available at private centres and will be added on the Co-WIN platform
It will be inclusion in the Covid vaccination programme as a booster dose for those above 18 years of age, official sources said.
In November, the nasal vaccine – BBV154 had received approval of the Drugs Controller General of India for restricted use in an emergency situation for those above 18 as a heterologous booster dose.
The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries.
Discussion about this post